Literature DB >> 17331868

Syme amputation for limb salvage: early experience with 26 cases.

Robert G Frykberg1, Suzanne Abraham, Edward Tierney, Jared Hall.   

Abstract

The Syme amputation is often overlooked as an alternative to below-knee amputation or above-knee amputation in cases of limb-threatening foot infections and gangrene. Even though the advantages of the Syme amputation over major amputation are well cited in the literature, many surgeons do not view this amputation as a viable option for limb salvage. We herein present our initial experience with this operation in a series of patients at imminent risk for major lower extremity amputation. This study included our initial 26 patients at high risk (92% had diabetes) with infection and/or significant peripheral arterial disease who underwent ankle disarticulation for limb salvage. Medical records were abstracted for pertinent demographic and clinical data. Variables of interest included diabetes status and duration, presence of peripheral arterial disease, infection, osteomyelitis, and gangrene. Our primary outcome variable was a healed amputation, whereas secondary outcomes included time to healing, subsequent major amputations, and complications. Despite prior recommendation for below-knee amputation or above-knee amputation in each of these patients, 50% remained healed at an average of 49.3 weeks of follow-up. Although 17 patients (65.4%) ambulated in a Syme prosthesis after healing of the original Syme operation, several patients went on to major amputation for progressive sepsis or recurrent ulcers, and 1 patient subsequently died. Because of the relatively small number of study subjects, we could find no significant predictors of success or failure of this procedure. However, all 10 patients eventually succumbing to major amputation and all 3 patients who died during follow-up had diabetes mellitus. At the end of follow-up, 46.2% (12/26) patients were functioning well in a Syme prosthesis. In this high-risk cohort of patients in whom major amputation had been recommended, we achieved a healing rate of 50% at an approximate 1-year follow-up. With the majority of patients having diabetes and peripheral vascular disease, we could not find any clear predictive factors for failure or successful outcome in this small population. Nonetheless, the Syme amputation deserves further study and consideration as a viable limb salvage option in patients threatened with major lower extremity amputation.

Entities:  

Mesh:

Year:  2007        PMID: 17331868     DOI: 10.1053/j.jfas.2006.11.005

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  5 in total

Review 1.  [Hindfoot amputations].

Authors:  S Rammelt; A Olbrich; H Zwipp
Journal:  Oper Orthop Traumatol       Date:  2011-10       Impact factor: 1.154

2.  Foot Osteomyelitis Location and Rates of Primary or Secondary Major Amputations in Patients With Diabetes.

Authors:  Elin Winkler; Madlaina Schöni; Nicola Krähenbühl; Ilker Uçkay; Felix W A Waibel
Journal:  Foot Ankle Int       Date:  2022-05-18       Impact factor: 3.569

3.  Results of the modified Pirogoff amputation with cannulated screws for diabetic foot infection.

Authors:  Abdul Aziz Mohd Nather; Jun-Cheong Kong; Muhammed Yaser Hasan; Ajay Purushothanam Nambiar
Journal:  Singapore Med J       Date:  2019-07       Impact factor: 1.858

4.  Limb salvage using advanced technologies: a case report.

Authors:  Robert G Frykberg; Rachel M O'Connor; Arthur Tallis; Edward Tierney
Journal:  Int Wound J       Date:  2013-02-21       Impact factor: 3.315

5.  [Minor amputations for diabetic foot syndrome].

Authors:  G Rümenapf; W Lang; S Morbach
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.